Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis. - Wikidata - awgldk - TriplyDB

Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis.

Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis.

http://www.wikidata.org/entity/Q38178804

about

Non-Small Cell Lung Cancer in a Very Young Woman: A Case Report and Critical Review of the Literature DNA-damaging autoantibodies and cancer: the lupus butterfly theory.Cancer risk in dermatomyositis: a meta-analysis of cohort studies.Systemic lupus erythematous and malignancy risk: a meta-analysis.Malignancies in systemic lupus erythematosus: a 2015 update.Gene-set meta-analysis of lung cancer identifies pathway related to systemic lupus erythematosus.Standardised incidence ratios (SIRs) for cancer after renal transplant in systemic lupus erythematosus (SLE) and non-SLE recipients.What investigations are needed to optimally monitor for malignancies in SLE?The evolving concept of SLE comorbidities.Systemic lupus erythematosus and malignancies risk.A20 SNP rs77191406 may be related to secondary cancer for rheumatoid arthritis and systemic lupus erythematosus patients.Case report: adrenal oncocytoma associated with markedly increased FDG uptake and immunohistochemically positive for GLUT1.

P2860

Q26777427-C2F74050-5D8B-4E95-8FFE-440F8CB2CA6C Q30251723-97988B5A-8C14-49A7-99A7-D4B0B1C0A96C Q34668158-B6C1AB8E-424B-4F63-A73D-12991FFA53B3 Q35464796-C98ED3E7-3597-4FB1-A4BB-E497E4E8793F Q36035448-EC79ECF2-7059-4608-97A3-CBE05BBBFD7E Q36300831-996C891F-5A96-4A9D-B2B7-51D24FE5D37C Q37007011-3735AA28-B383-490D-9685-A7FD1393FD11 Q38367994-AC624109-2B6F-40C0-9CFC-70CEB6FCAFDD Q39283399-F665A187-D837-469E-A871-D24C2D684ACB Q41441163-00C11C95-1367-44CE-BA97-271FB21150F0 Q51630171-5DEE3DA7-AEC3-4428-9518-E696CBA66F62 Q53047451-A1C020BB-0957-409F-8310-FF34DCCCFAFD

P2860

Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis.

http://www.wikidata.org/entity/Q38178804

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Lung, liver, prostate, bladder ...... evidence from a meta-analysis.

@en

type

label

Lung, liver, prostate, bladder ...... evidence from a meta-analysis.

@en

prefLabel

Lung, liver, prostate, bladder ...... evidence from a meta-analysis.

@en

P1433

Q38178804-32048DCE-DC4A-4A05-B0B1-10EF62AD2B1C

P1476

Q38178804-20DEF928-D284-475F-B008-6D184C550CDE

P2093

Q38178804-03333F5B-7BDE-4639-A4BD-F5FB1493DCD6

Q38178804-59669607-8936-4323-BC0D-0D61E501AFB4

Q38178804-5A10D75E-B5FD-4870-B7B9-605F48256F3C

Q38178804-9C591D89-0614-4A23-A81F-4FD9A99E36D3

Q38178804-AE80CAE8-1E49-4FCA-9647-4107413C3DE0

Q38178804-BC6AF2DB-BE12-4FFD-81C0-F1FFABC4ADC2

Q38178804-CB2A2E47-6EB3-4B63-8758-2AC6D4697518

Q38178804-F4D236FD-E7F4-40D5-8FAE-85C7940217B6

P2860

Q38178804-05DEEA7B-F1D2-467B-B258-11C935CBB17C

Q38178804-084F2439-F3C4-4BA3-A4DD-62B04DCF0D4D

Q38178804-0F0C861E-5910-47B9-BEE3-8AF0C8F7B757

Q38178804-1223D33F-8BD8-460F-B272-C64D9E1C3B8E

Q38178804-1B315191-D95E-4D22-B478-EF3177B33B92

Q38178804-1DA1534B-92FF-4611-AA0C-520B42096A6A

Q38178804-46CC4B1C-DE56-4715-9C4D-80999F03871B

Q38178804-53CDA001-6669-40E4-8D7B-9C0381BD641E

Q38178804-5C044A45-4A99-477B-8177-72E848AE1432

Q38178804-5CDFD417-7960-4030-8652-606BCC21DA62

P304

Q38178804-2965AB3C-B27E-47F1-BA20-2BEFCB53AEEA

P31

Q38178804-30D7AB0E-03DC-45E4-8B9D-5802C377A5EE

Q38178804-41ba632c-0d65-452c-93e8-bc48d0dbf9d4

P356

Q38178804-50E944F6-F9ED-4F93-B65B-15ACA83A9812

P433

Q38178804-A5CBC863-72DF-4A81-8CCA-D84E79A7107D

P478

Q38178804-78641CF4-21CE-422F-AD32-B506B1C9D7BF

P50

Q38178804-53BA2845-686B-497C-81A7-ABADA4BB136D

Q38178804-A9DF263E-59F3-4DBD-97C3-C89BE7B84E15

P577

Q38178804-50B4D34B-BAE0-46A4-BA36-D937F3A9D596

P698

Q38178804-5E14BC89-C605-4049-A184-996B5EAA67C5

P356

0961203313520060

P1433

P1476

Lung, liver, prostate, bladder ...... evidence from a meta-analysis

@en

P2093

D-Q Ye

http://www.w3.org/2001/XMLSchema#string

H Cen

http://www.w3.org/2001/XMLSchema#string

J Ni

http://www.w3.org/2001/XMLSchema#string

L-F Hu

http://www.w3.org/2001/XMLSchema#string

L-J Qiu

http://www.w3.org/2001/XMLSchema#string

M Zhang

http://www.w3.org/2001/XMLSchema#string

P-F Wen

http://www.w3.org/2001/XMLSchema#string

X-S Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Cardiovascular disease in lupus: insights and updates

Quantifying heterogeneity in a meta-analysis

Meta-analysis in clinical trials

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study

Bladder complications in patients receiving cyclophosphamide for systemic lupus erythematosus or rheumatoid arthritis

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review.

Quantitative methods in the review of epidemiologic literature.

Association of OX40L polymorphisms with sporadic breast cancer in northeast Chinese Han population.

P304

284-292

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0961203313520060

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-01-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24429300

http://www.w3.org/2001/XMLSchema#string